Intra-abdominal metastases from soft tissue sarcoma.

Area of Science:

• Oncology
• Surgical Oncology
• Medical Research

Background:

• Abdominal metastasis from soft tissue sarcoma (STS) is an uncommon occurrence.
• Understanding the clinical features and prognosis of STS abdominal metastases is crucial for patient management.

Purpose of the Study:

• To define the clinical characteristics of patients with abdominal metastasis originating from primary soft tissue sarcoma.
• To evaluate the prognosis and survival outcomes for patients diagnosed with abdominal STS metastases.

Main Methods:

• A retrospective analysis of patients with abdominal metastasis from STS was conducted.
• Data were collected from the Royal Marsden Hospital Sarcoma Unit prospective database between January 1990 and July 2001.

Main Results:

• Nineteen patients (0.9%) developed abdominal metastasis from STS. Common symptoms included intestinal obstruction and abdominal pain. Myxoid liposarcoma and leiomyosarcoma were frequent histologies.
• Abdominal metastatectomy was performed in 16 patients, showing a trend towards improved median survival (33 months vs. 8 months for unresected patients).
• One- and 2-year disease-specific survival rates were 66% and 43%, respectively, with a median survival of 13 months.

Conclusions:

• Abdominal metastasis from STS, while rare, necessitates careful monitoring and thorough investigation in symptomatic patients.
• Surgery is indicated for acute presentations, but the overall survival for patients with abdominal STS metastasis remains limited.
• Vigilance for metastatic disease is essential in the management of soft tissue sarcoma.